Jingyan Yi

Southwest Medical University — China

Medicine · Health Sciences

10h-index366citations26works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian function and disorders(5), PARP inhibition in cancer therapy(4), Reproductive Biology and Fertility(2), Cancer-related Molecular Pathways(2), Dermatology and Skin Diseases(2)

Publications26 total

Precision-based solutions for endometriosis: Integrating immunomics and drug repositioning strategies
International Immunopharmacology·2026
Unveiling estrogen’s role: a comprehensive review of its impact on skin health and disease
APOPTOSIS·2026
Targeted Delivery of Nucleic Acid Therapeutics: Emerging Carriers and Applications in Common Metabolic and Inflammatory Diseases
International Journal of Nanomedicine·2026Open Access
TSPAN4 controls vascular smooth muscle cell phenotypic switching and intimal hyperplasia by targeting TPM1-regulated cytoskeletal organization
Clinical Science·2025· 2 citedOpen Access
The role of tetraspanins in organ fibrosis: mechanisms and therapeutic perspectives
Journal of Translational Medicine·2025Open Access
Innovative approaches in skin therapy: The rise of organoid cultivation
Chemical Engineering Journal·2025· 5 cited
Advances in cardiac organoid research: implications for cardiovascular disease treatment
Cardiovascular Diabetology·2025· 15 citedOpen Access
Hormonal influence: unraveling the impact of sex hormones on vascular smooth muscle cells
Biological Research·2024· 3 citedOpen Access
The utilization of nanotechnology in the female reproductive system and related disorders
Heliyon·2024· 25 citedOpen Access
Dried <i>Zingiber officinale</i> Alleviates Dehydroepiandrosterone‐Induced Ovarian Granulosa Cell Apoptosis via the Reactive Oxygen Species‐Mediated Pathway
Journal of Food Biochemistry·2024Open Access
Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of asparagus against polycystic ovary syndrome
Journal of Ovarian Research·2023· 10 citedOpen Access
Micelle encapsulation zinc‐doped copper oxide nanocomposites reverse Olaparib resistance in ovarian cancer by disrupting homologous recombination repair
Bioengineering & Translational Medicine·2023· 13 citedOpen Access
Ferredoxin 1 regulates granulosa cell apoptosis and autophagy in polycystic ovary syndrome
Clinical Science·2023· 48 citedOpen Access
Network Pharmacology Analysis and Experimental Pharmacology Study Explore the Mechanism of Asparagus against Glioblastoma
Journal of Food Biochemistry·2023· 1 citedOpen Access
Author response for "Micelle encapsulation zinc‐doped copper oxide nanocomposites reverse Olaparib resistance in ovarian cancer by disrupting homologous recombination repair"
2023
Author response for "Micelle encapsulation zinc‐doped copper oxide nanocomposites reverse Olaparib resistance in ovarian cancer by disrupting homologous recombination repair"
2022
Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome
Endocrine·2022· 4 cited
The c.323 G&gt;C mutation in LORICRIN causes new-found late-onset autosomal dominant loricrin keratoderma in a Chinese Han Pedigree
Journal of Dermatological Science·2022· 2 cited
Comprehensive analysis of LASS6 expression and prognostic value in ovarian cancer
Journal of Ovarian Research·2021· 3 citedOpen Access
Research update on the anticancer effects of buparlisib (Review)
Oncology Letters·2021· 23 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Jinshan Xing(12), Gan Qiao(9), Pixu Liu(6), Xin Luo(6), Lanlin Shen(5), Hailing Cheng(5), Keran Jia(5), Chongya Liu(4), Xiaolin Sang(4), Yijue Xue(4), Chunxiang Zhang(4), Zhiwei Tao(3), Shaokun Chen(3), Yuan Zhang(3), Ziteng Huang(3), Yadan Tan(3), Aharon Gedanken(3), Xiukun Lin(3), Chunxiang Zhang(3), Shengbiao Li(3)